TAZ Promotes PC2 Degradation through a SCF^β-Trcp E3 Ligase Complex

REFERENCES

• Ahn, M. Y., S. C. Bae, M. Maruyama, and Y. Ito. 1996. Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFα gene family. Gene 168:279–280.
   PubMedGoogle Scholar
• Amsterdam, A., S. Burgess, G. Golling, W. Chen, Z. Sun, K. Townsend, S. Farrington, M. Haldi, and N. Hopkins. 1999. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 13:2713–2724.
   PubMed Web of Science ®Google Scholar
• Bai, C., P. Sen, K. Hofmann, L. Ma, M. Goebl, J. W. Harper, and S. J. Elledge. 1996. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86:263–274.
   PubMed Web of Science ®Google Scholar
• Bhunia, A. K., K. Piontek, A. Boletta, L. Liu, F. Qian, P. N. Xu, F. J. Germino, and G. G. Germino. 2002. PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109:157–168.
   PubMed Web of Science ®Google Scholar
• Busino, L., M. Donzelli, M. Chiesa, D. Guardavaccaro, D. Ganoth, N. V. Dorrello, A. Hershko, M. Pagano, and G. F. Draetta. 2003. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426:87–91.
   PubMed Web of Science ®Google Scholar
• Cai, Y., G. Anyatonwu, D. Okuhara, K. B. Lee, Z. Yu, T. Onoe, C. L. Mei, Q. Qian, L. Geng, R. Wiztgall, B. E. Ehrlich, and S. Somlo. 2004. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 279:19987–19995.
   PubMedGoogle Scholar
• Calvet, J. P. 2002. Cilia in PKD—letting it all hang out. J. Am. Soc. Nephrol. 13:2614–2616.
   PubMedGoogle Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193–199.
   PubMed Web of Science ®Google Scholar
• Cui, C. B., L. F. Cooper, X. Yang, G. Karsenty, and I. Aukhil. 2003. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 23:1004–1013.
   PubMedGoogle Scholar
• Delmas, P., S. M. Nauli, X. Li, B. Coste, N. Osorio, M. Crest, D. A. Brown, and J. Zhou. 2004. Gating of the polycystin ion channel signaling complex in neurons and kidney cells. FASEB J. 18:740–742.
   PubMedGoogle Scholar
• Delmas, P., H. Nomura, X. Li, M. Lakkis, Y. Luo, Y. Segal, J. M. Fernandez-Fernandez, P. Harris, A. M. Frischauf, D. A. Brown, and J. Zhou. 2002. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J. Biol. Chem. 277:11276–11283.
   PubMedGoogle Scholar
• Dick, L. R., A. A. Cruikshank, L. Grenier, F. D. Melandri, S. L. Nunes, and R. L. Stein. 1996. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin β-lactone. J. Biol. Chem. 271:7273–7276.
   PubMed Web of Science ®Google Scholar
• Drummond, I. A., A. Majumdar, H. Hentschel, M. Elger, L. Solnica-Krezel, A. F. Schier, S. C. Neuhauss, D. L. Stemple, F. Zwartkruis, Z. Rangini, W. Driever, and M. C. Fishman. 1998. Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 125:4655–4667.
   PubMed Web of Science ®Google Scholar
• Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726–731.
   PubMed Web of Science ®Google Scholar
• Flaherty, L., E. C. Bryda, D. Collins, U. Rudofsky, and J. C. Montogomery. 1995. New mouse model for polycystic kidney disease with both recessive and dominant gene effects. Kidney Int. 47:552–558.
   PubMedGoogle Scholar
• Fry, J. L., Jr., W. E. Koch, J. C. Jennette, E. McFarland, F. A. Fried, and J. Mandell. 1985. A genetically determined murine model of infantile polycystic kidney disease. J. Urol. 134:828–833.
   PubMedGoogle Scholar
• Gonzalez-Perrett, S., K. Kim, C. Ibarra, A. E. Damiano, E. Zotta, M. Batelli, P. C. Harris, I. L. Reisin, M. A. Arnaout, and H. F. Cantiello. 2001. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc. Natl. Acad. Sci. USA 98:1182–1187.
   PubMedGoogle Scholar
• Guay-Woodford, L. M. 2003. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Renal Physiol. 285:F1034–F1049.
   PubMed Web of Science ®Google Scholar
• Guay-Woodford, L. M., E. C. Bryda, B. Christine, J. R. Lindsey, W. R. Collier, E. D. Avner, P. D'Eustachio, and L. Flaherty. 1996. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney Int. 50:1158–1165.
   PubMed Web of Science ®Google Scholar
• Hanaoka, K., F. Qian, A. Boletta, A. K. Bhunia, K. Piontek, L. Tsiokas, V. P. Sukhatme, W. B. Guggino, and G. G. Germino. 2000. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408:990–994.
   PubMed Web of Science ®Google Scholar
• Hong, J. H., E. S. Hwang, M. T. McManus, A. Amsterdam, Y. Tian, R. Kalmukova, E. Mueller, T. Benjamin, B. M. Spiegelman, P. A. Sharp, N. Hopkins, and M. B. Yaffe. 2005. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074–1078.
   PubMed Web of Science ®Google Scholar
• Hossain, Z., S. M. Ali, H. L. Ko, J. Xu, C. P. Ng, K. Guo, Z. Qi, S. Ponniah, W. Hong, and W. Hunziker. 2007. Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. USA 104:1631–1636.
   PubMedGoogle Scholar
• Hughes, J., C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. L. San Millan, V. Gamble, and P. C. Harris. 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10:151–160.
   PubMed Web of Science ®Google Scholar
• Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129–4135.
   PubMed Web of Science ®Google Scholar
• Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918–4927.
   PubMed Web of Science ®Google Scholar
• International Polycystic Kidney Disease Consortium. 1995. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81:289–298.
   PubMedGoogle Scholar
• Ito, Y. 1989. Signals and transcription factors. Gan To Kagaku Ryoho 16:509–515. (In Japanese.)
   PubMedGoogle Scholar
• Jin, J., T. Shirogane, L. Xu, G. Nalepa, J. Qin, S. J. Elledge, and J. W. Harper. 2003. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:3062–3074.
   PubMed Web of Science ®Google Scholar
• Kanai, F., P. A. Marignani, D. Sarbassova, R. Yagi, R. A. Hall, M. Donowitz, A. Hisaminato, T. Fujiwara, Y. Ito, L. C. Cantley, and M. B. Yaffe. 2000. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19:6778–6791.
   PubMed Web of Science ®Google Scholar
• Kimberling, W. J., P. R. Fain, J. B. Kenyon, D. Goldgar, E. Sujansky, and P. A. Gabow. 1988. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N. Engl. J. Med. 319:913–918.
   PubMed Web of Science ®Google Scholar
• Koulen, P., Y. Cai, L. Geng, Y. Maeda, S. Nishimura, R. Witzgall, B. E. Ehrlich, and S. Somlo. 2002. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4:191–197.
   PubMed Web of Science ®Google Scholar
• Koulen, P., R. S. Duncan, J. Liu, N. E. Cohen, J. A. Yannazzo, N. McClung, C. L. Lockhart, M. Branden, and M. Buechner. 2005. Polycystin-2 accelerates Ca2+ release from intracellular stores in Caenorhabditis elegans. Cell Calcium 37:593–601.
   PubMedGoogle Scholar
• Lantinga-van Leeuwen, I. S., J. G. Dauwerse, H. J. Baelde, W. N. Leonhard, A. van de Wal, C. J. Ward, S. Verbeek, M. C. Deruiter, M. H. Breuning, E. de Heer, and D. J. Peters. 2004. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13:3069–3077.
   PubMed Web of Science ®Google Scholar
• Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, H. M. Kim, W. J. Kim, H. Yamamoto, N. Yamashita, T. Yano, T. Ikeda, S. Itohara, J. Inazawa, T. Abe, A. Hagiwara, H. Yamagishi, A. Ooe, A. Kaneda, T. Sugimura, T. Ushijima, S. C. Bae, and Y. Ito. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113–124.
   PubMed Web of Science ®Google Scholar
• Lund, A. H., and M. van Lohuizen. 2002. RUNX: a trilogy of cancer genes. Cancer Cell 1:213–215.
   PubMedGoogle Scholar
• Luo, Y., P. M. Vassilev, X. Li, Y. Kawanabe, and J. Zhou. 2003. Native polycystin 2 functions as a plasma membrane Ca2+-permeable cation channel in renal epithelia. Mol. Cell. Biol. 23:2600–2607.
   PubMed Web of Science ®Google Scholar
• Mahoney, W. M., Jr., J. H. Hong, M. B. Yaffe, and I. K. Farrance. 2005. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388:217–225.
   PubMedGoogle Scholar
• Mochizuki, T., G. Wu, T. Hayashi, S. L. Xenophontos, B. Veldhuisen, J. J. Saris, D. M. Reynolds, Y. Cai, P. A. Gabow, A. Pierides, W. J. Kimberling, M. H. Breuning, C. C. Deltas, D. J. Peters, and S. Somlo. 1996. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339–1342.
   PubMed Web of Science ®Google Scholar
• Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063–1066.
   PubMed Web of Science ®Google Scholar
• Murakami, M., M. Nakagawa, E. N. Olson, and O. Nakagawa. 2005. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. USA 102:18034–18039.
   PubMedGoogle Scholar
• Murakami, M., J. Tominaga, R. Makita, Y. Uchijima, Y. Kurihara, O. Nakagawa, T. Asano, and H. Kurihara. 2006. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem. Biophys. Res. Commun. 339:533–539.
   PubMed Web of Science ®Google Scholar
• Nauli, S. M., F. J. Alenghat, Y. Luo, E. Williams, P. Vassilev, X. Li, A. E. Elia, W. Lu, E. M. Brown, S. J. Quinn, D. E. Ingber, and J. Zhou. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33:129–137.
   PubMed Web of Science ®Google Scholar
• Nauli, S. M., and J. Zhou. 2004. Polycystins and mechanosensation in renal and nodal cilia. Bioessays 26:844–856.
   PubMedGoogle Scholar
• Nawaz, Z., D. M. Lonard, C. L. Smith, E. Lev-Lehman, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1182–1189.
   PubMed Web of Science ®Google Scholar
• Park, K. S., J. A. Whitsett, T. Di Palma, J. H. Hong, M. B. Yaffe, and M. Zannini. 2004. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J. Biol. Chem. 279:17384–17390.
   PubMedGoogle Scholar
• Parnell, S. C., B. S. Magenheimer, R. L. Maser, C. A. Zien, A. M. Frischauf, and J. P. Calvet. 2002. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J. Biol. Chem. 277:19566–19572.
   PubMed Web of Science ®Google Scholar
• Pazour, G. J., B. L. Dickert, Y. Vucica, E. S. Seeley, J. L. Rosenbaum, G. B. Witman, and D. G. Cole. 2000. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell Biol. 151:709–718.
   PubMed Web of Science ®Google Scholar
• Pei, Y., T. Watnick, N. He, K. Wang, Y. Liang, P. Parfrey, G. Germino, and P. St. George-Hyslop. 1999. Somatic PKD2 mutations in individual kidney and liver cysts support a “two-hit” model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10:1524–1529.
   PubMed Web of Science ®Google Scholar
• Peters, D. J., and L. A. Sandkuijl. 1992. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib. Nephrol. 97:128–139.
   PubMedGoogle Scholar
• Preminger, G. M., W. E. Koch, F. A. Fried, E. McFarland, E. D. Murphy, and J. Mandell. 1982. Murine congenital polycystic kidney disease: a model for studying development of cystic disease. J. Urol. 127:556–560.
   PubMedGoogle Scholar
• Pritchard, L., J. A. Sloane-Stanley, J. A. Sharpe, R. Aspinwall, W. Lu, V. Buckle, L. Strmecki, D. Walker, C. J. Ward, C. E. Alpers, J. Zhou, W. G. Wood, and P. C. Harris. 2000. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum. Mol. Genet. 9:2617–2627.
   PubMedGoogle Scholar
• Qian, F., F. J. Germino, Y. Cai, X. Zhang, S. Somlo, and G. G. Germino. 1997. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16:179–183.
   PubMed Web of Science ®Google Scholar
• Qian, F., T. J. Watnick, L. F. Onuchic, and G. G. Germino. 1996. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87:979–987.
   PubMed Web of Science ®Google Scholar
• Reeders, S. T. 1992. Multilocus polycystic disease. Nat. Genet. 1:235–237.
   PubMedGoogle Scholar
• Satake, M., T. Ibaraki, Y. Yamaguchi, and Y. Ito. 1989. Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J. Virol. 63:3669–3677.
   PubMedGoogle Scholar
• Shao, X., J. E. Johnson, J. A. Richardson, T. Hiesberger, and P. Igarashi. 2002. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 13:1824–1836.
   PubMedGoogle Scholar
• Sun, Z., A. Amsterdam, G. J. Pazour, D. G. Cole, M. S. Miller, and N. Hopkins. 2004. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131:4085–4093.
   PubMed Web of Science ®Google Scholar
• Takahashi, H., J. P. Calvet, D. Dittemore-Hoover, K. Yoshida, J. J. Grantham, and V. H. Gattone II. 1991. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J. Am. Soc. Nephrol 1:980–989.
   PubMedGoogle Scholar
• Tian, Y., D. Li, J. Dahl, J. You, and T. Benjamin. 2004. Identification of TAZ as a binding partner of the polyomavirus T antigens. J. Virol. 78:12657–12664.
   PubMedGoogle Scholar
• Tsiokas, L., E. Kim, T. Arnould, V. P. Sukhatme, and G. Walz. 1997. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. USA 94:6965–6970.
   PubMed Web of Science ®Google Scholar
• Tsvetkov, L. M., K. H. Yeh, S. J. Lee, H. Sun, and H. Zhang. 1999. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664.
   PubMed Web of Science ®Google Scholar
• Vassilev, P. M., L. Guo, X. Z. Chen, Y. Segal, J. B. Peng, N. Basora, H. Babakhanlou, G. Cruger, M. Kanazirska, C. Ye, E. M. Brown, M. A. Hediger, and J. Zhou. 2001. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca2+ homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 282:341–350.
   PubMed Web of Science ®Google Scholar
• Winocour, E. 1963. Purification of polyomavirus. Virology 19:158–168.
   PubMed Web of Science ®Google Scholar
• Winston, J. T., P. Strack, P. Beer-Romero, C. Y. Chu, S. J. Elledge, and J. W. Harper. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13:270–283.
   PubMed Web of Science ®Google Scholar
• Wu, G., V. D'Agati, Y. Cai, G. Markowitz, J. H. Park, D. M. Reynolds, Y. Maeda, T. C. Le, H. Hou, Jr., R. Kucherlapati, W. Edelmann, and S. Somlo. 1998. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93:177–188.
   PubMed Web of Science ®Google Scholar
• Wu, G., and S. Somlo. 2000. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol. Genet. Metab. 69:1–15.
   PubMed Web of Science ®Google Scholar
• Yoder, B. K., X. Hou, and L. M. Guay-Woodford. 2002. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 13:2508–2516.
   PubMed Web of Science ®Google Scholar
• Zolotnitskaya, A., and L. M. Satlin. 1999. Developmental expression of ROMK in rat kidney. Am. J. Physiol. 276:F825–F836.
   PubMedGoogle Scholar